| Drug 1 | |
| Generic/Working Name | Sorafenib |
| Trade Name | Nexavar |
| Company Name | Bayer |
| Drug Type | Small molecule |
| Drug Class | Tyrosine Kinase inhibitor |
| Dose | 400 mg b.i.d. |
| Route | oral (p.o.) |
| Schedule of Administration | Starting dose: 200 mg b.i.d. with ramp‐dosing to the maximum dose of 400 mg b.i.d. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.